SwePub
Sök i LIBRIS databas

  Utökad sökning

WFRF:(Skaftason A.)
 

Sökning: WFRF:(Skaftason A.) > Comparative analysi...

Comparative analysis of targeted next-generation sequencing panels for the detection of gene mutations in chronic lymphocytic leukemia: an ERIC multi-center study

Sutton, LA (författare)
Karolinska Inst, Dept Mol Med & Surg, Stockholm, Sweden.
Ljungström, Viktor, 1986- (författare)
Uppsala universitet,Science for Life Laboratory, SciLifeLab,Experimentell och klinisk onkologi,Karolinska Inst, Dept Mol Med & Surg, Stockholm, Sweden.
Enjuanes, A (författare)
Inst Invest Biomed August Pi i Sunyer IDIBAPS, Barcelona, Spain.;Ctr Invest Biomed Red Canc CIBERONC, Barcelona, Spain.;Univ Barcelona, Hosp Clin Barcelona, Barcelona, Spain.
visa fler...
Cortese, D (författare)
Karolinska Inst, Dept Mol Med & Surg, Stockholm, Sweden.
Skaftason, A (författare)
Karolinska Institutet,Karolinska Inst, Dept Mol Med & Surg, Stockholm, Sweden.
Tausch, E (författare)
Ulm Univ, Dept Internal Med 3, Ulm, Germany.
Kozubik, KS (författare)
Masaryk Univ, Ctr Mol Med, CEITEC Cent European Inst Technol, Brno, Czech Republic.,Ulm Univ, Dept Internal Med 3, Ulm, Germany.,Karolinska Inst, Dept Mol Med & Surg, Stockholm, Sweden.;Ctr Res & Technol, Inst Appl Biosci, Thessaloniki, Greece.
Nadeu, F (författare)
Inst Invest Biomed August Pi i Sunyer IDIBAPS, Barcelona, Spain.;Ctr Invest Biomed Red Canc CIBERONC, Barcelona, Spain.;Univ Barcelona, Hosp Clin Barcelona, Barcelona, Spain.
Armand, M (författare)
Sorbonne Univ, Hop Pitie Salpetriere, AP HP, Dept Hematol, Paris, France.
Malcikova, J (författare)
Masaryk Univ, Ctr Mol Med, CEITEC Cent European Inst Technol, Brno, Czech Republic.
Pandzic, T (författare)
Forster, J (författare)
Univ Southampton, Fac Med, Canc Sci, Southampton, Hants, England.
Davis, Z (författare)
Royal Bournemouth Hosp, Dept Hematol, Bournemouth, Dorset, England.
Oscier, D (författare)
Royal Bournemouth Hosp, Dept Hematol, Bournemouth, Dorset, England.
Rossi, D (författare)
Oncol Inst Southern Switzerland, Hematol Dept, Bellinzona, Switzerland.;Inst Oncol Res, Bellinzona, Switzerland.
Ghia, P (författare)
Univ Vita Salute San Raffaele, Div Expt Oncol, Milan, Italy.;IRCCS, San Raffaele Sci Inst, Milan, Italy.
Strefford, JC (författare)
Univ Southampton, Fac Med, Canc Sci, Southampton, Hants, England.
Pospisilova, S (författare)
Masaryk Univ, Ctr Mol Med, CEITEC Cent European Inst Technol, Brno, Czech Republic.
Stilgenbauer, S (författare)
Davi, F (författare)
Sorbonne Univ, Hop Pitie Salpetriere, AP HP, Dept Hematol, Paris, France.
Campo, E (författare)
Inst Invest Biomed August Pi i Sunyer IDIBAPS, Barcelona, Spain.;Ctr Invest Biomed Red Canc CIBERONC, Barcelona, Spain.;Univ Barcelona, Hosp Clin Barcelona, Barcelona, Spain.
Stamatopoulos, K (författare)
Karolinska Institutet
Rosenquist, R (författare)
Karolinska Institutet,Karolinska Inst, Dept Mol Med & Surg, Stockholm, Sweden.;Karolinska Univ Hosp, Karolinska Univ Lab, Clin Genet, Stockholm, Sweden.
Djureinovic, Tatjana (författare)
Uppsala universitet,Experimentell och klinisk onkologi,Science for Life Laboratory, SciLifeLab,Medicinsk genetik och genomik
visa färre...
Karolinska Inst, Dept Mol Med & Surg, Stockholm, Sweden Science for Life Laboratory, SciLifeLab (creator_code:org_t)
2020-04-09
2021
Engelska.
Ingår i: Haematologica. - : Ferrata Storti Foundation (Haematologica). - 1592-8721 .- 0390-6078. ; 106:3, s. 682-691
  • Tidskriftsartikel (refereegranskat)
Abstract Ämnesord
Stäng  
  • Next-generation sequencing (NGS) has transitioned from research to clinical routine, yet the comparability of different technologies for mutation profiling remains an open question. We performed a European multicenter (n=6) evaluation of three amplicon-based NGS assays targeting 11 genes recurrently mutated in chronic lymphocytic leukemia. Each assay was assessed by two centers using 48 pre-characterized chronic lymphocytic leukemia samples; libraries were sequenced on the Illumina MiSeq instrument and bioinformatics analyses were centralized. Across all centers the median percentage of target reads ≥100x ranged from 94.2-99.8%. To rule out assay-specific technical variability, we first assessed variant calling at the individual assay level i.e. pairwise analysis of variants detected amongst partner centers. After filtering for variants present in the paired normal sample and removal of PCR/sequencing artefacts, the panels achieved 96.2% (Multiplicom), 97.7% (TruSeq) and 90% (HaloPlex) concordance at a VAF >0.5%. Reproducibility was assessed by looking at the inter-laboratory variation in detecting mutations and 107/115 (93% concordance) of mutations were detected by all 6 centers, while the remaining 8/115 (7%) variants were undetected by a single center and 6/8 of these variants concerned minor subclonal mutations (VAF <5%). We sought to investigate low-frequency mutations further by using a high-sensitivity assay containing unique molecular identifiers, which confirmed the presence of several minor subclonal mutations. Thus, while amplicon-based approaches can be adopted for somatic mutation detection with VAFs >5%, after rigorous validation, the use of unique molecular identifiers may be necessary to reach a higher sensitivity and ensure consistent and accurate detection of low-frequency variants.

Ämnesord

MEDICIN OCH HÄLSOVETENSKAP  -- Klinisk medicin -- Hematologi (hsv//swe)
MEDICAL AND HEALTH SCIENCES  -- Clinical Medicine -- Hematology (hsv//eng)

Publikations- och innehållstyp

ref (ämneskategori)
art (ämneskategori)

Hitta via bibliotek

Till lärosätets databas

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Stäng

Kopiera och spara länken för att återkomma till aktuell vy